NL-OMON43959
Recruiting
Not Applicable
An exploratory pharmacokinetic and pharmacodynamic study of beta-lactam and fluoroquinolone in ICU patients - EXPAT
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Sepsis
- Sponsor
- Erasmus MC, Universitair Medisch Centrum Rotterdam
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All the patients admitted to the ICU or internal medicine ward and given standard of care intravenous therapy of either one or both of the target antibiotic classes are included. Antibiotic initiation based on clinical suspicion of infection and/or cultured pathogens susceptible to the target drugs, initial dosage prescription, and duration of therapy are at the discretion of the attending physician. ;In order to be eligible to participate in this study, a subject must also meet all of the following criteria:
- •\* Written informed consent has been obtained from the patient or their legally authorized representative.
- •\* Receiving intravenous antibiotic therapy of the target drugs.
- •\* Suitable intravenous/intra\-arterial access to facilitate sample collection.
- •\* Treatment should be aimed for at least at 3 days.
- •\* Bacterial isolates sample are obtainable before start of the target drugs.
Exclusion Criteria
- •\* Consent not obtained.
- •\* \<18 years of age.
- •\* Antibiotic cessation within 72h after start of the therapie.
- •\* Medium care and burn wound patients admitted to the ICU.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Examining the pharmacokinetic and pharmacodynamic profile of biperidegeheugen/ memoryNL-OMON24672Maastricht University27
Recruiting
Not Applicable
Examining the pharmacokinetic and pharmacodynamic profile of biperideNL-OMON47428niversiteit Maastricht42
Active, not recruiting
Not Applicable
Evaluation of pharmacokinetic and pharmacodynamic interactions between escitalopram and drugs used for the treatment of bipolar disorders. - NDbipolar disordersMedDRA version: 9.1Level: LLTClassification code 10057667Term: Bipolar disorderEUCTR2008-000370-20-ITAZIENDA OSPEDALIERA PISANA
Completed
Not Applicable
Bioequivalence Study of Filgrastim in Healthy Human VolunteersHealthy volunteers.IRCT20130626013776N7AryaTinaGene Biopharmaceutical Co24
Recruiting
Not Applicable
Bioequivalence Study of Somatropin in Healthy Human Volunteers..IRCT20130626013776N20AryaTinaGene Biopharmaceutical Co30